2004 Protocol meaning

In this issue: Public Law case law quarterly—Q3 2025 Equality and Human rights Constitutional and administrative law Brexit SIs Post-Brexit transition guidance Judicial review Public procurement Public sector contracts State security and intelligence Information law Other Public law news LexTalk®Public Law: a Lexis®Nexis community Daily and weekly news alerts New and updated content Dates for your diary Trackers Useful information Public Law case law quarterly—Q3 2025 The quarterly Public Law case law round-up presents and evaluates significant judgments brought together by the Lexis+® UK Public Law team each quarter. Marking 25 years since the Human Rights Act 1998 took effect, this edition begins with insight into recent human rights jurisprudence. See News Analysis: Public Law case law quarterly—Q3 2025. Equality and Human rights ECtHR rejects prisoner voting claim—Hora v UK In Hora v United Kingdom (Application no 1048/20), the European Court of Human Rights...

In this issue: Brexit headlines Brexit SIs Post-Brexit guidance Constitutional and administrative law Judicial review Equality and human rights Information law Public procurement Subsidy control and State aid State security and intelligence Other Public Law news Daily and weekly news alerts New and updated content Dates for your diary Trackers Useful information Brexit headlines Commons Library assesses Murphy’s review on democratic oversight of the Windsor Framework The Commons Library has issued a briefing on the independent review of the Windsor Framework, commissioned by Secretary of State for Northern Ireland, Hilary Benn MP, and chaired by Lord Murphy of Torfaen, with the report expected by 10 July 2025. Set up in February 2023 to revise the Protocol on Ireland/Northern Ireland and prevent a hard border, the Framework is being scrutinised to identify how it can operate with support from all communities in Northern Ireland. The commission follows a...

Role of the Pensions Regulator Statutory objectives The Pensions Regulator’s core function is to meet the statutory objectives set out in section 5 of the Pensions Act 2004 (PeA 2004). These are: to safeguard the benefits due to, or on behalf of, members of occupational pension schemes to safeguard the benefits due to, or on behalf of, members of personal pension schemes who are: employees for whom there are 'direct payment arrangements' (defined below), and where the scheme is a stakeholder pension scheme, any other members to reduce the likelihood of circumstances that could lead to compensation from the Pension Protection Fund for defined benefit scheme funding, to minimise any adverse effect on an employer’s sustainable growth to maximise compliance with auto-enrolment duties (for further information on which, see Practice Note: Auto-enrolment—an introduction) to promote, and improve understanding of, the good administration of 'work-based pension schemes', namely: ...

Issue Details Convention on Third Party Liability in the Field of Nuclear Energy (Paris Convention) Parties: 16 parties Revisions: 1963 Convention Supplementary to the Paris Convention (Brussels Supplementary Convention — entered into force on 4 December 1974) 1964 Protocol — entered into force on 1 April 1968 1982 Protocol — entered into force on 7 October 1988 2004 Protocol — 1 January 2022 Location: Paris Adopted: 29 July 1960 Came into force: 1 April 1968 Subject: Nuclear liability What is the international liability regime for nuclear damage? Civil liability for nuclear harm is defined by four principal instruments: the 1960 Paris Convention on Third Party Liability in the Field of Nuclear Energy (Paris Convention); the 1963 Brussels Convention Supplementary to the Paris Convention (Brussels Supplementary Convention); the 1963 Vienna Convention on Civil Liability for Nuclear Damage (Vienna Convention); and the Convention on Supplementary Compensation...

This Practice Note Introduces the testing of medicinal products in people, commonly called clinical trials, and outlines the UK regime governing such studies. It explains the amendments made to domestic rules relating to clinical trials by the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (UK CTR 2025), SI 2025/538. Practical points are examined too, covering, how to seek authorisation to run a clinical trial, how to manage and bring a trial to a close, how to draft a clinical trial protocol, and links to a range of clinical trial agreements (CTAs). It also charts the stages of clinical trials (phases I, II, III and IV), identifies the parties involved, addresses informed consent, and highlights specific provisions for children and adults lacking capacity. The note briefly reviews trials undertaken beyond the UK and, as well as this, touches on adjacent legal topics, such as data protection for clinical trial data and personal data, clinical trial disclosure, and the research and Bolar exemptions under patent law. The UK and...